Last edition
News about "Fibrodysplasia Ossificans Progressiva (FOP)"
US FDA Approves Atebrioz from Mirum and Incyte
The US FDA has approved Atebrioz (zilurgisertib) from Mirum and Incyte for adult and pediatric patients with Fibrodysplasia Ossificans Progressiva (FOP).
Fibrodysplasia Ossificans Progressiva (FOP) | 28/09/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members